Substance / Medication

Peptide

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

No related conditions have been mapped yet. Condition-intervention linkages are derived from SNOMED CT relationships and will expand as the knowledge graph grows.

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Bowel preparation quality in patients using glucagon-like peptide-1 agonists: a systematic review and meta-analysis.
Ahmed Zohaib, Iqbal Amna, Arif Syeda Faiza et al. · Gastrointest Endosc · 2026
PMID: 40846241Meta-Analysis
N-terminal Pro-brain Natriuretic Peptide as a Prognostic Biomarker for Cardiac Surgeries: A Systematic Review.
Queiroz Barbara Giovanna Souza Silva, Arruda Andressa Maranhão de, Villa-Chan Lara Maria Moura de Sá et al. · Braz J Cardiovasc Surg · 2026
PMID: 41196806Meta-AnalysisFull text (PMC)
Evaluation of Nile Tilapia () Skin Peptides for Wound Healing: A Systematic and Meta-Analysis Review.
Tozetto Rodrigo, de Macedo Julia B, da Silva Thais Leticia M et al. · ACS Biomater Sci Eng · 2026
PMID: 41329667Meta-AnalysisFull text (PMC)
Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis.
Ahmed Warda, Gandhi Om H, Yu Nathan et al. · J Neurol Sci · 2026
PMID: 41468715Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Peptide (substance)
SNOMED CT
52642002
UMLS CUI
C0030956

Clinical Data

This intervention maps to 0 entities in the Ltrl knowledge graph.

0
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.